Amgen (NQ: AMGN )
319.31
+1.16
(+0.36%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 25, 2024
Add to My Watchlist
Headline News about Amgen
![](https://g.foolcdn.com/editorial/images/704322/biotech-laboratory-at-work-getty.jpg)
![](https://prudentbiotech.com/wp-content/uploads/2022/10/Yield-and-XBI.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_27965.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_27957.jpeg?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/704389/rising-chart.jpg)
![](https://www.investors.com/wp-content/uploads/2018/01/Stock-amgen-01-shutt.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_16902.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/10/11/earl_blumenauer_.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/10/11/image18.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/10/11/image-apple2.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/10/09/joe_biden_jlhervas2.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_27899.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For October 11, 2022
October 11, 2022
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/08/valuestocks1600.png)
![](https://g.foolcdn.com/editorial/images/703896/a-customer-shops-at-a-pharmacy.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/valuestock_image_3248.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/10/03/shutterstock_1262036452.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/02/reit_housing_down_1600-1024x576.png)
![](https://investorplace.com/wp-content/uploads/2022/08/hidden-bull-market.png)
![](https://cdn.benzinga.com/files/images/story/2022/09/23/shutterstock_2080639498.jpg?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2019/05/Stock-IonisHQ-01-company.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/valuestock_image_3073.jpeg?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2017/12/Stock-Biotech-11-Adobe.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/09/19/screenshot_2022-09-19_at_11.08.00_pm.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/16/pill-_image_by_arek_socha_from_pixabay_.jpg?width=1200&height=800&fit=crop)
Top US Drugmakers Exploit US Patent System To Keep Generic Competition At Bay: Report
September 16, 2022
Via Benzinga
![](https://www.investors.com/wp-content/uploads/2017/12/Stock-biotech-12-adobe.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/09/14/pill-_image_by_arek_socha_from_pixabay_.jpg?width=1200&height=800&fit=crop)
US Department Of Health, Defense To Inject $1B To Boost Domestic Biomanufacturing
September 14, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/09/13/cancer-image_by_pdpics_from_pixabay-.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/12/image24.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2019/09/bmy1600a.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.